Reviewing health and costs after whole-exome genetic testing
This study looks at real-world health outcomes and costs after whole-exome genetic testing done through the Tapestry program. Your results—whether they find something or not—are used to understand what happens next and how care decisions may change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are part of the Tapestry program and already received your genetic test results
- You are 18 years old or older
- You have an established Mayo Clinic provider before joining Tapestry
- You can give consent for yourself (you do not need a legal representative)
- You are not in prison
- If the study will use your medical chart, you must have a Minnesota research authorization on file
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced testing (called multi-omics) to look at your genes, proteins, and other molecules to discover new things about health and disease. You'll need to be a Mayo Clinic patient, able to receive packages, and not have a history of blood cancer or a donor bone marrow transplant.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This trial is about building a large library of genetic test results (whole exome or whole genome sequencing) that researchers can use. You may be eligible if your sequencing data is available and you (or your study contact) can be reached again so researchers can include your information responsibly.
This study looks at how well different genetic tests (whole exome/genome sequencing and standard genetic tests) work for diagnosing rare genetic diseases and inherited cancer conditions. It may help confirm which testing approach provides the clearest results for families.
This study aims to use advanced genetic testing to better understand rare and genetic diseases. It may help find a diagnosis or guide personalized care for you or your child.
This trial looks at the tumor’s DNA to help doctors choose the best next treatment for people with advanced cancer. It’s testing whether this “exome” genetic analysis can improve therapeutic decisions for newly treated metastatic or locally advanced solid tumors.
Hear when a new Health Care Utilization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.